SCHEMBL6050482

SCHEMBL6050482

O=c1[nH]c2ccccc2c(-c2ccccc2)c1N1CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
HSD17B10 Q99714 5/20 0.55
NPSR1 Q6W5P4 5/20 0.55
KDM4E B2RXH2 4/20 0.55
TSHR P16473 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
CASP1 P29466 2/20 0.55
CASP7 P55210 2/20 0.55
HPGD P15428 5/20 0.50
MAPT P10636 2/20 0.50
PDE9A O76083 1/20 0.49
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
PARP1 P09874 1/20 0.46
USP2 O75604 1/20 0.45
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394356 1.00 ALDH1A1 (0.55) ALDH1A1HSD17B10NPSR1KDM4ETSHR
SCHEMBL16795045 0.87 ALDH1A1 (0.46) ALDH1A1HSD17B10NPSR1KDM4ETSHR
SCHEMBL28274604 0.78 HTR2A (0.51) ALDH1A1HPGDESR1ESR2HTR6
SCHEMBL17510042 0.77 PARP1 (0.48) ALDH1A1HSD17B10KDM4ETSHRSMN1; SMN2
SCHEMBL10572503 0.77 KDM4E (0.57) ALDH1A1HSD17B10KDM4ETSHRHPGD
SCHEMBL16814410 0.76 ALDH1A1 (0.62) ALDH1A1HSD17B10NPSR1KDM4ETSHR
SCHEMBL10077099 0.74 HTR6 (0.49) ALDH1A1HSD17B10TSHRHPGDMAPT
SCHEMBL14349887 0.74 PDE9A (0.52) PDE9APARP1
SCHEMBL28132803 0.73 MAPT (0.71) ALDH1A1HSD17B10KDM4ESMN1; SMN2HPGD
SCHEMBL16814411 0.73 CYP1A2 (0.47) HSD17B10TSHRCYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1368008-B1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF THE PARTIAL DOPAMINE-D2 AGONIST ARIPIPRAZOL LOHMANN THERAPIE SYST LTS (DE) 2006-09-27 EP disclosed